Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parathyroid Glands--Diseases”

738 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 738 results

Testing effectiveness (Phase 2)Looking for participantsNCT06906874
What this trial is testing

Activated Charcoal Use in Chronic Kidney Disease Patients

Who this might be right for
End Stage Renal Disease (ESRD)CKD 5D, HemodialysisCKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Mansoura University 40
Not applicableStudy completedNCT01937520
What this trial is testing

Acupuncture for Reduction of Inflammation

Who this might be right for
Thyroid or Parathyroid Surgery
Rutgers, The State University of New Jersey 20
Not applicableNot Yet RecruitingNCT07628543
What this trial is testing

Computer Vision-Based Recognition of Parathyroid Glands and Recurrent Laryngeal Nerves in Endoscopic Surgery

Who this might be right for
Thyroid DiseasesThyroid Neoplasms
Fujian Medical University 100
Post-approval studies (Phase 4)Study completedNCT02910466
What this trial is testing

Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in Hypoparathyroidism

Who this might be right for
Chronic HypoparathyroidismHypoparathyroidism
Shire 39
Testing effectiveness (Phase 2)Study completedNCT00730210
What this trial is testing

Treatment of Hypoparathyroidism With Subcutaneous PTH (1-84) Injections: Effects on Muscle Function and Quality of Life

Who this might be right for
Hypoparathyroidism
University of Aarhus 62
Not applicableStudy completedNCT01539486
What this trial is testing

Relationship of Preoperative Parathyroid Hormone (PTH) and Ex-Vivo Gamma Counts in Minimally Invasive Parathyroidectomy

Who this might be right for
Parathyroid Disease
University of Arkansas 29
Not applicableStudy completedNCT01691781
What this trial is testing

The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study

Who this might be right for
Hyperparathyroidism
Brigham and Women's Hospital 41
Not applicableApproved For MarketingNCT05654701
What this trial is testing

Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism

Who this might be right for
Hypoparathyroidism
Ascendis Pharma Bone Diseases A/S
Post-approval studies (Phase 4)UnknownNCT05720273
What this trial is testing

Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients

Who this might be right for
Chronic Kidney Disease-Mineral and Bone Disorder
Xiaoyan Jia 80
Not applicableLooking for participantsNCT00556530
What this trial is testing

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome

Who this might be right for
DiGeorge Syndrome22q11.2 Deletion Syndrome
Albert Einstein College of Medicine 1,000
Post-approval studies (Phase 4)Study completedNCT01100723
What this trial is testing

Trial to Optimize Mineral Outcomes in Dialysis Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
University of Colorado, Denver 92
Large-scale testing (Phase 3)Looking for participantsNCT05891769
What this trial is testing

99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT

Who this might be right for
Parathyroid Adenoma
Andrei Iagaru 100
Not applicableActive Not RecruitingNCT05227287
What this trial is testing

ADH1 and ADH2 Disease Monitoring Study (DMS)

Who this might be right for
Autosomal Dominant Hypocalcemia
Calcilytix Therapeutics, Inc., a BridgeBio company 95
Post-approval studies (Phase 4)Study completedNCT03182699
What this trial is testing

Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease Requiring Chronic DialysisLeft Ventricular Hypertrophy
Rainer Oberbauer 62
Not applicableEnrolling By InvitationNCT07173621
What this trial is testing

Comparing the Impact of AMNIOEFFECT Application vs Standard of Care on Post-Operative Healing in Patients Who Have Undergone Thyroid and Parathyroid Surgery Via the Transcutaneous Approach

Who this might be right for
Thyroid; WoundParathyroid DiseasesSurgical Incision+1 more
Sarasota Memorial Health Care System 334
Not applicableStudy completedNCT05022667
What this trial is testing

Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Total Thyroidectomy

Who this might be right for
Thyroid NeoplasmsThyroid DiseasesHypoparathyroidism+6 more
University of Michigan 114
Not applicableLooking for participantsNCT05573828
What this trial is testing

Usefulness of ICG Angiography-Guided Thyroidectomy for Preserving Parathyroid Function

Who this might be right for
Iatrogenic Hypocalcemia
Hospital Universitari de Bellvitge 394
Testing effectiveness (Phase 2)Study completedNCT01254565
What this trial is testing

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 87
Large-scale testing (Phase 3)Ended earlyNCT05543928
What this trial is testing

Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism

Who this might be right for
Chronic Kidney Disease stage3Chronic Kidney Disease stage4Vitamin d Deficiency+1 more
OPKO Health, Inc. 2
Not applicableStudy completedNCT00477516
What this trial is testing

Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients

Who this might be right for
End-Stage Renal Disease
James B. Wetmore, MD 18
Load More Results